世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

市販薬の世界市場 2023-2027


Global Over-The-Counter Drug Market 2023-2027

市販薬の世界市場 2023-2027年市販薬市場は2022-2027年に585億4000万米ドル成長し、予測期間中のCAGRは6.53%で加速すると予測されています。当レポートでは、市販薬市場の全体的な分析、市場規模と予測、動向、成... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ 		2023年10月6日 US$2,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		173 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

市販薬の世界市場 2023-2027年市販薬市場は2022-2027年に585億4000万米ドル成長し、予測期間中のCAGRは6.53%で加速すると予測されています。当レポートでは、市販薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。Technavioの市販薬市場は以下のようにセグメント化されています：投与経路別経口トピカル非経口その他流通チャネル別オフラインオンライン地域別北米ヨーロッパアジアその他の地域（ROW）本調査では、今後数年間の一般用医薬品市場の成長を促進する主な理由の1つとして、老人人口の増加を挙げています。また、医療費の増加や一般用医薬品のeコマースプラットフォームの採用拡大も、市場の大きな需要につながるでしょう。一般用医薬品市場に関する本レポートは、以下の分野をカバーしています：市販薬市場サイジング市販薬市場予測市販薬市場の業界分析本レポートでは、お客様が市場での地位を向上できるよう、しっかりとしたベンダー分析を行っており、これに基づき、アボット・ラボラトリーズ、アケリオス・セラピューティクス、アストラゼネカ、バイエル、バイオガイア、ベーリンガー・インゲルハイム・インターナショナル、Bukwang Pharmaceutical Co.Ltd.、Chr Hansen Holding AS、Cipla Ltd.、CVS Health Corp.、Eli Lilly and Co.、GlaxoSmithKline Plc、Johnson and Johnson Services Inc.、Lupin Ltd.、Mankind Pharma Ltd.、Novartis AG、Pfizer Inc.、Reckitt Benckiser Group Plc、Sanofi SA、Zydus Lifesciences Ltd.などである。また、一般用医薬品市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。この調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細情報については、https://www.technavio.com/report/over-the-counter-drug-market-analysisThe をご覧ください。本レポートは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る


目次

1 Executive Summary 1.1 Market overview Exhibit 01: Executive Summary - Chart on Market Overview Exhibit 02: Executive Summary - Data Table on Market Overview Exhibit 03: Executive Summary - Chart on Global Market Characteristics Exhibit 04: Executive Summary - Chart on Market by Geography Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel Exhibit 07: Executive Summary - Chart on Incremental Growth Exhibit 08: Executive Summary - Data Table on Incremental Growth Exhibit 09: Executive Summary - Chart on Vendor Market Positioning 2 Market Landscape 2.1 Market ecosystem Exhibit 10: Parent market Exhibit 11: Market Characteristics 3 Market Sizing 3.1 Market definition Exhibit 12: Offerings of vendors included in the market definition 3.2 Market segment analysis Exhibit 13: Market segments 3.3 Market size 2022 3.4 Market outlook: Forecast for 2022-2027 Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion) Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion) Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%) Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) 4 Historic Market Size 4.1 Global over-the-counter drug market 2017 - 2021 Exhibit 18: Historic Market Size - Data Table on global over-the-counter drug market 2017 - 2021 ($ billion) 4.2 Route of Administration Segment Analysis 2017 - 2021 Exhibit 19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ billion) 4.3 Distribution Channel Segment Analysis 2017 - 2021 Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion) 4.4 Geography Segment Analysis 2017 - 2021 Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion) 4.5 Country Segment Analysis 2017 - 2021 Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion) 5 Five Forces Analysis 5.1 Five forces summary Exhibit 23: Five forces analysis - Comparison between 2022 and 2027 5.2 Bargaining power of buyers Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027 5.3 Bargaining power of suppliers Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027 5.4 Threat of new entrants Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027 5.5 Threat of substitutes Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027 5.6 Threat of rivalry Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027 5.7 Market condition Exhibit 29: Chart on Market condition - Five forces 2022 and 2027 6 Market Segmentation by Route of Administration 6.1 Market segments Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%) Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%) 6.2 Comparison by Route of Administration Exhibit 32: Chart on Comparison by Route of Administration Exhibit 33: Data Table on Comparison by Route of Administration 6.3 Oral - Market size and forecast 2022-2027 Exhibit 34: Chart on Oral - Market size and forecast 2022-2027 ($ billion) Exhibit 35: Data Table on Oral - Market size and forecast 2022-2027 ($ billion) Exhibit 36: Chart on Oral - Year-over-year growth 2022-2027 (%) Exhibit 37: Data Table on Oral - Year-over-year growth 2022-2027 (%) 6.4 Topical - Market size and forecast 2022-2027 Exhibit 38: Chart on Topical - Market size and forecast 2022-2027 ($ billion) Exhibit 39: Data Table on Topical - Market size and forecast 2022-2027 ($ billion) Exhibit 40: Chart on Topical - Year-over-year growth 2022-2027 (%) Exhibit 41: Data Table on Topical - Year-over-year growth 2022-2027 (%) 6.5 Parenteral - Market size and forecast 2022-2027 Exhibit 42: Chart on Parenteral - Market size and forecast 2022-2027 ($ billion) Exhibit 43: Data Table on Parenteral - Market size and forecast 2022-2027 ($ billion) Exhibit 44: Chart on Parenteral - Year-over-year growth 2022-2027 (%) Exhibit 45: Data Table on Parenteral - Year-over-year growth 2022-2027 (%) 6.6 Others - Market size and forecast 2022-2027 Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ billion) Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ billion) Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%) Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%) 6.7 Market opportunity by Route of Administration Exhibit 50: Market opportunity by Route of Administration ($ billion) Exhibit 51: Data Table on Market opportunity by Route of Administration ($ billion) 7 Market Segmentation by Distribution Channel 7.1 Market segments Exhibit 52: Chart on Distribution Channel - Market share 2022-2027 (%) Exhibit 53: Data Table on Distribution Channel - Market share 2022-2027 (%) 7.2 Comparison by Distribution Channel Exhibit 54: Chart on Comparison by Distribution Channel Exhibit 55: Data Table on Comparison by Distribution Channel 7.3 Offline - Market size and forecast 2022-2027 Exhibit 56: Chart on Offline - Market size and forecast 2022-2027 ($ billion) Exhibit 57: Data Table on Offline - Market size and forecast 2022-2027 ($ billion) Exhibit 58: Chart on Offline - Year-over-year growth 2022-2027 (%) Exhibit 59: Data Table on Offline - Year-over-year growth 2022-2027 (%) 7.4 Online - Market size and forecast 2022-2027 Exhibit 60: Chart on Online - Market size and forecast 2022-2027 ($ billion) Exhibit 61: Data Table on Online - Market size and forecast 2022-2027 ($ billion) Exhibit 62: Chart on Online - Year-over-year growth 2022-2027 (%) Exhibit 63: Data Table on Online - Year-over-year growth 2022-2027 (%) 7.5 Market opportunity by Distribution Channel Exhibit 64: Market opportunity by Distribution Channel ($ billion) Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ billion) 8 Customer Landscape 8.1 Customer landscape overview Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria 9 Geographic Landscape 9.1 Geographic segmentation Exhibit 67: Chart on Market share by geography 2022-2027 (%) Exhibit 68: Data Table on Market share by geography 2022-2027 (%) 9.2 Geographic comparison Exhibit 69: Chart on Geographic comparison Exhibit 70: Data Table on Geographic comparison 9.3 North America - Market size and forecast 2022-2027 Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ billion) Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ billion) Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%) Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%) 9.4 Europe - Market size and forecast 2022-2027 Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ billion) Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ billion) Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%) Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%) 9.5 Asia - Market size and forecast 2022-2027 Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ billion) Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ billion) Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%) Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%) 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion) Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion) Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) 9.7 US - Market size and forecast 2022-2027 Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ billion) Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ billion) Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%) Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%) 9.8 Germany - Market size and forecast 2022-2027 Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ billion) Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ billion) Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%) Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%) 9.9 Japan - Market size and forecast 2022-2027 Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ billion) Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ billion) Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%) Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%) 9.10 UK - Market size and forecast 2022-2027 Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ billion) Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ billion) Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%) Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%) 9.11 China - Market size and forecast 2022-2027 Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ billion) Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ billion) Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%) Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%) 9.12 Market opportunity by geography Exhibit 107: Market opportunity by geography ($ billion) Exhibit 108: Data Tables on Market opportunity by geography ($ billion) 10 Drivers, Challenges, and Trends 10.1 Market drivers 10.2 Market challenges 10.3 Impact of drivers and challenges Exhibit 109: Impact of drivers and challenges in 2022 and 2027 10.4 Market trends 11 Vendor Landscape 11.1 Overview 11.2 Vendor landscape Exhibit 110: Overview on Criticality of inputs and Factors of differentiation 11.3 Landscape disruption Exhibit 111: Overview on factors of disruption 11.4 Industry risks Exhibit 112: Impact of key risks on business 12 Vendor Analysis 12.1 Vendors covered Exhibit 113: Vendors covered 12.2 Market positioning of vendors Exhibit 114: Matrix on vendor position and classification 12.3 Abbott Laboratories Exhibit 115: Abbott Laboratories - Overview Exhibit 116: Abbott Laboratories - Business segments Exhibit 117: Abbott Laboratories - Key news Exhibit 118: Abbott Laboratories - Key offerings Exhibit 119: Abbott Laboratories - Segment focus 12.4 Achelios Therapeutics Inc. Exhibit 120: Achelios Therapeutics Inc. - Overview Exhibit 121: Achelios Therapeutics Inc. - Product / Service Exhibit 122: Achelios Therapeutics Inc. - Key offerings 12.5 AstraZeneca Plc Exhibit 123: AstraZeneca Plc - Overview Exhibit 124: AstraZeneca Plc - Product / Service Exhibit 125: AstraZeneca Plc - Key news Exhibit 126: AstraZeneca Plc - Key offerings 12.6 Bayer AG Exhibit 127: Bayer AG - Overview Exhibit 128: Bayer AG - Business segments Exhibit 129: Bayer AG - Key news Exhibit 130: Bayer AG - Key offerings Exhibit 131: Bayer AG - Segment focus 12.7 BioGaia AB Exhibit 132: BioGaia AB - Overview Exhibit 133: BioGaia AB - Business segments Exhibit 134: BioGaia AB - Key news Exhibit 135: BioGaia AB - Key offerings Exhibit 136: BioGaia AB - Segment focus 12.8 Boehringer Ingelheim International GmbH Exhibit 137: Boehringer Ingelheim International GmbH - Overview Exhibit 138: Boehringer Ingelheim International GmbH - Business segments Exhibit 139: Boehringer Ingelheim International GmbH - Key news Exhibit 140: Boehringer Ingelheim International GmbH - Key offerings Exhibit 141: Boehringer Ingelheim International GmbH - Segment focus 12.9 Bukwang Pharmaceutical Co. Ltd. Exhibit 142: Bukwang Pharmaceutical Co. Ltd. - Overview Exhibit 143: Bukwang Pharmaceutical Co. Ltd. - Product / Service Exhibit 144: Bukwang Pharmaceutical Co. Ltd. - Key offerings 12.10 Chr Hansen Holding AS Exhibit 145: Chr Hansen Holding AS - Overview Exhibit 146: Chr Hansen Holding AS - Business segments Exhibit 147: Chr Hansen Holding AS - Key news Exhibit 148: Chr Hansen Holding AS - Key offerings Exhibit 149: Chr Hansen Holding AS - Segment focus 12.11 CVS Health Corp. Exhibit 150: CVS Health Corp. - Overview Exhibit 151: CVS Health Corp. - Business segments Exhibit 152: CVS Health Corp. - Key news Exhibit 153: CVS Health Corp. - Key offerings Exhibit 154: CVS Health Corp. - Segment focus 12.12 GlaxoSmithKline Plc Exhibit 155: GlaxoSmithKline Plc - Overview Exhibit 156: GlaxoSmithKline Plc - Business segments Exhibit 157: GlaxoSmithKline Plc - Key news Exhibit 158: GlaxoSmithKline Plc - Key offerings Exhibit 159: GlaxoSmithKline Plc - Segment focus 12.13 Johnson and Johnson Services Inc. Exhibit 160: Johnson and Johnson Services Inc. - Overview Exhibit 161: Johnson and Johnson Services Inc. - Business segments Exhibit 162: Johnson and Johnson Services Inc. - Key news Exhibit 163: Johnson and Johnson Services Inc. - Key offerings Exhibit 164: Johnson and Johnson Services Inc. - Segment focus 12.14 Novartis AG Exhibit 165: Novartis AG - Overview Exhibit 166: Novartis AG - Business segments Exhibit 167: Novartis AG - Key offerings Exhibit 168: Novartis AG - Segment focus 12.15 Pfizer Inc. Exhibit 169: Pfizer Inc. - Overview Exhibit 170: Pfizer Inc. - Product / Service Exhibit 171: Pfizer Inc. - Key news Exhibit 172: Pfizer Inc. - Key offerings 12.16 Reckitt Benckiser Group Plc Exhibit 173: Reckitt Benckiser Group Plc - Overview Exhibit 174: Reckitt Benckiser Group Plc - Business segments Exhibit 175: Reckitt Benckiser Group Plc - Key offerings Exhibit 176: Reckitt Benckiser Group Plc - Segment focus 12.17 Sanofi SA Exhibit 177: Sanofi SA - Overview Exhibit 178: Sanofi SA - Business segments Exhibit 179: Sanofi SA - Key news Exhibit 180: Sanofi SA - Key offerings Exhibit 181: Sanofi SA - Segment focus 13 Appendix 13.1 Scope of the report 13.2 Inclusions and exclusions checklist Exhibit 182: Inclusions checklist Exhibit 183: Exclusions checklist 13.3 Currency conversion rates for US$ Exhibit 184: Currency conversion rates for US$ 13.4 Research methodology Exhibit 185: Research methodology Exhibit 186: Validation techniques employed for market sizing Exhibit 187: Information sources 13.5 List of abbreviations Exhibit 188: List of abbreviations Exhibits: Exhibits1: Executive Summary - Chart on Market Overview Exhibits2: Executive Summary - Data Table on Market Overview Exhibits3: Executive Summary - Chart on Global Market Characteristics Exhibits4: Executive Summary - Chart on Market by Geography Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel Exhibits7: Executive Summary - Chart on Incremental Growth Exhibits8: Executive Summary - Data Table on Incremental Growth Exhibits9: Executive Summary - Chart on Vendor Market Positioning Exhibits10: Parent market Exhibits11: Market Characteristics Exhibits12: Offerings of vendors included in the market definition Exhibits13: Market segments Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion) Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion) Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%) Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) Exhibits18: Historic Market Size - Data Table on global over-the-counter drug market 2017 - 2021 ($ billion) Exhibits19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ billion) Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion) Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion) Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion) Exhibits23: Five forces analysis - Comparison between 2022 and 2027 Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027 Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027 Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027 Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027 Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027 Exhibits29: Chart on Market condition - Five forces 2022 and 2027 Exhibits30: Chart on Route of Administration - Market share 2022-2027 (%) Exhibits31: Data Table on Route of Administration - Market share 2022-2027 (%) Exhibits32: Chart on Comparison by Route of Administration Exhibits33: Data Table on Comparison by Route of Administration Exhibits34: Chart on Oral - Market size and forecast 2022-2027 ($ billion) Exhibits35: Data Table on Oral - Market size and forecast 2022-2027 ($ billion) Exhibits36: Chart on Oral - Year-over-year growth 2022-2027 (%) Exhibits37: Data Table on Oral - Year-over-year growth 2022-2027 (%) Exhibits38: Chart on Topical - Market size and forecast 2022-2027 ($ billion) Exhibits39: Data Table on Topical - Market size and forecast 2022-2027 ($ billion) Exhibits40: Chart on Topical - Year-over-year growth 2022-2027 (%) Exhibits41: Data Table on Topical - Year-over-year growth 2022-2027 (%) Exhibits42: Chart on Parenteral - Market size and forecast 2022-2027 ($ billion) Exhibits43: Data Table on Parenteral - Market size and forecast 2022-2027 ($ billion) Exhibits44: Chart on Parenteral - Year-over-year growth 2022-2027 (%) Exhibits45: Data Table on Parenteral - Year-over-year growth 2022-2027 (%) Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ billion) Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ billion) Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%) Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%) Exhibits50: Market opportunity by Route of Administration ($ billion) Exhibits51: Data Table on Market opportunity by Route of Administration ($ billion) Exhibits52: Chart on Distribution Channel - Market share 2022-2027 (%) Exhibits53: Data Table on Distribution Channel - Market share 2022-2027 (%) Exhibits54: Chart on Comparison by Distribution Channel Exhibits55: Data Table on Comparison by Distribution Channel Exhibits56: Chart on Offline - Market size and forecast 2022-2027 ($ billion) Exhibits57: Data Table on Offline - Market size and forecast 2022-2027 ($ billion) Exhibits58: Chart on Offline - Year-over-year growth 2022-2027 (%) Exhibits59: Data Table on Offline - Year-over-year growth 2022-2027 (%) Exhibits60: Chart on Online - Market size and forecast 2022-2027 ($ billion) Exhibits61: Data Table on Online - Market size and forecast 2022-2027 ($ billion) Exhibits62: Chart on Online - Year-over-year growth 2022-2027 (%) Exhibits63: Data Table on Online - Year-over-year growth 2022-2027 (%) Exhibits64: Market opportunity by Distribution Channel ($ billion) Exhibits65: Data Table on Market opportunity by Distribution Channel ($ billion) Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Exhibits67: Chart on Market share by geography 2022-2027 (%) Exhibits68: Data Table on Market share by geography 2022-2027 (%) Exhibits69: Chart on Geographic comparison Exhibits70: Data Table on Geographic comparison Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ billion) Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ billion) Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%) Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%) Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ billion) Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ billion) Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%) Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%) Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ billion) Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ billion) Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%) Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%) Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion) Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion) Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ billion) Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ billion) Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%) Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%) Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ billion) Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ billion) Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%) Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%) Exhibits95: Chart on Japan - Market size and forecast 2022-2027 ($ billion) Exhibits96: Data Table on Japan - Market size and forecast 2022-2027 ($ billion) Exhibits97: Chart on Japan - Year-over-year growth 2022-2027 (%) Exhibits98: Data Table on Japan - Year-over-year growth 2022-2027 (%) Exhibits99: Chart on UK - Market size and forecast 2022-2027 ($ billion) Exhibits100: Data Table on UK - Market size and forecast 2022-2027 ($ billion) Exhibits101: Chart on UK - Year-over-year growth 2022-2027 (%) Exhibits102: Data Table on UK - Year-over-year growth 2022-2027 (%) Exhibits103: Chart on China - Market size and forecast 2022-2027 ($ billion) Exhibits104: Data Table on China - Market size and forecast 2022-2027 ($ billion) Exhibits105: Chart on China - Year-over-year growth 2022-2027 (%) Exhibits106: Data Table on China - Year-over-year growth 2022-2027 (%) Exhibits107: Market opportunity by geography ($ billion) Exhibits108: Data Tables on Market opportunity by geography ($ billion) Exhibits109: Impact of drivers and challenges in 2022 and 2027 Exhibits110: Overview on Criticality of inputs and Factors of differentiation Exhibits111: Overview on factors of disruption Exhibits112: Impact of key risks on business Exhibits113: Vendors covered Exhibits114: Matrix on vendor position and classification Exhibits115: Abbott Laboratories - Overview Exhibits116: Abbott Laboratories - Business segments Exhibits117: Abbott Laboratories - Key news Exhibits118: Abbott Laboratories - Key offerings Exhibits119: Abbott Laboratories - Segment focus Exhibits120: Achelios Therapeutics Inc. - Overview Exhibits121: Achelios Therapeutics Inc. - Product / Service Exhibits122: Achelios Therapeutics Inc. - Key offerings Exhibits123: AstraZeneca Plc - Overview Exhibits124: AstraZeneca Plc - Product / Service Exhibits125: AstraZeneca Plc - Key news Exhibits126: AstraZeneca Plc - Key offerings Exhibits127: Bayer AG - Overview Exhibits128: Bayer AG - Business segments Exhibits129: Bayer AG - Key news Exhibits130: Bayer AG - Key offerings Exhibits131: Bayer AG - Segment focus Exhibits132: BioGaia AB - Overview Exhibits133: BioGaia AB - Business segments Exhibits134: BioGaia AB - Key news Exhibits135: BioGaia AB - Key offerings Exhibits136: BioGaia AB - Segment focus Exhibits137: Boehringer Ingelheim International GmbH - Overview Exhibits138: Boehringer Ingelheim International GmbH - Business segments Exhibits139: Boehringer Ingelheim International GmbH - Key news Exhibits140: Boehringer Ingelheim International GmbH - Key offerings Exhibits141: Boehringer Ingelheim International GmbH - Segment focus Exhibits142: Bukwang Pharmaceutical Co. Ltd. - Overview Exhibits143: Bukwang Pharmaceutical Co. Ltd. - Product / Service Exhibits144: Bukwang Pharmaceutical Co. Ltd. - Key offerings Exhibits145: Chr Hansen Holding AS - Overview Exhibits146: Chr Hansen Holding AS - Business segments Exhibits147: Chr Hansen Holding AS - Key news Exhibits148: Chr Hansen Holding AS - Key offerings Exhibits149: Chr Hansen Holding AS - Segment focus Exhibits150: CVS Health Corp. - Overview Exhibits151: CVS Health Corp. - Business segments Exhibits152: CVS Health Corp. - Key news Exhibits153: CVS Health Corp. - Key offerings Exhibits154: CVS Health Corp. - Segment focus Exhibits155: GlaxoSmithKline Plc - Overview Exhibits156: GlaxoSmithKline Plc - Business segments Exhibits157: GlaxoSmithKline Plc - Key news Exhibits158: GlaxoSmithKline Plc - Key offerings Exhibits159: GlaxoSmithKline Plc - Segment focus Exhibits160: Johnson and Johnson Services Inc. - Overview Exhibits161: Johnson and Johnson Services Inc. - Business segments Exhibits162: Johnson and Johnson Services Inc. - Key news Exhibits163: Johnson and Johnson Services Inc. - Key offerings Exhibits164: Johnson and Johnson Services Inc. - Segment focus Exhibits165: Novartis AG - Overview Exhibits166: Novartis AG - Business segments Exhibits167: Novartis AG - Key offerings Exhibits168: Novartis AG - Segment focus Exhibits169: Pfizer Inc. - Overview Exhibits170: Pfizer Inc. - Product / Service Exhibits171: Pfizer Inc. - Key news Exhibits172: Pfizer Inc. - Key offerings Exhibits173: Reckitt Benckiser Group Plc - Overview Exhibits174: Reckitt Benckiser Group Plc - Business segments Exhibits175: Reckitt Benckiser Group Plc - Key offerings Exhibits176: Reckitt Benckiser Group Plc - Segment focus Exhibits177: Sanofi SA - Overview Exhibits178: Sanofi SA - Business segments Exhibits179: Sanofi SA - Key news Exhibits180: Sanofi SA - Key offerings Exhibits181: Sanofi SA - Segment focus Exhibits182: Inclusions checklist Exhibits183: Exclusions checklist Exhibits184: Currency conversion rates for US$ Exhibits185: Research methodology Exhibits186: Validation techniques employed for market sizing Exhibits187: Information sources Exhibits188: List of abbreviations

　

ページTOPに戻る


　

Summary

Global Over-The-Counter Drug Market 2023-2027 The over-the-counter drug market is forecasted to grow by USD 58.54 bn during 2022-2027, accelerating at a CAGR of 6.53% during the forecast period. The report on the over-the-counter drug market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by new product launches in global over-the-counter drug market, the rising prevalence of diseases and OTC drug use, and favorable regulatory framework for OTC drugs. Technavio's over-the-counter drug market is segmented as below: By Route Of Administration Oral Topical Parenteral Others By Distribution Channel Offline Online By Geography North America Europe Asia Rest of World (ROW) This study identifies the increasing number of geriatric population as one of the prime reasons driving the over-the-counter drug market growth during the next few years. Also, increasing healthcare expenditure and growing adoption of e-commerce platforms for OTC drugs will lead to sizable demand in the market. The report on the over-the-counter drug market covers the following areas: Over-the-counter drug market sizing Over-the-counter drug market forecast Over-the-counter drug market industry analysis The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading over-the-counter drug market vendors that include Abbott Laboratories, Achelios Therapeutics Inc., AstraZeneca Plc, Bayer AG, BioGaia AB, Boehringer Ingelheim International GmbH, Bukwang Pharmaceutical Co. Ltd., Chr Hansen Holding AS, Cipla Ltd., CVS Health Corp., Eli Lilly and Co., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Lupin Ltd., Mankind Pharma Ltd., Novartis AG, Pfizer Inc., Reckitt Benckiser Group Plc, Sanofi SA, and Zydus Lifesciences Ltd.. Also, the over-the-counter drug market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/over-the-counter-drug-market-analysis The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

ページTOPに戻る


Table of Contents

1 Executive Summary 1.1 Market overview Exhibit 01: Executive Summary - Chart on Market Overview Exhibit 02: Executive Summary - Data Table on Market Overview Exhibit 03: Executive Summary - Chart on Global Market Characteristics Exhibit 04: Executive Summary - Chart on Market by Geography Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel Exhibit 07: Executive Summary - Chart on Incremental Growth Exhibit 08: Executive Summary - Data Table on Incremental Growth Exhibit 09: Executive Summary - Chart on Vendor Market Positioning 2 Market Landscape 2.1 Market ecosystem Exhibit 10: Parent market Exhibit 11: Market Characteristics 3 Market Sizing 3.1 Market definition Exhibit 12: Offerings of vendors included in the market definition 3.2 Market segment analysis Exhibit 13: Market segments 3.3 Market size 2022 3.4 Market outlook: Forecast for 2022-2027 Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion) Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion) Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%) Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) 4 Historic Market Size 4.1 Global over-the-counter drug market 2017 - 2021 Exhibit 18: Historic Market Size - Data Table on global over-the-counter drug market 2017 - 2021 ($ billion) 4.2 Route of Administration Segment Analysis 2017 - 2021 Exhibit 19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ billion) 4.3 Distribution Channel Segment Analysis 2017 - 2021 Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion) 4.4 Geography Segment Analysis 2017 - 2021 Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion) 4.5 Country Segment Analysis 2017 - 2021 Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion) 5 Five Forces Analysis 5.1 Five forces summary Exhibit 23: Five forces analysis - Comparison between 2022 and 2027 5.2 Bargaining power of buyers Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027 5.3 Bargaining power of suppliers Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027 5.4 Threat of new entrants Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027 5.5 Threat of substitutes Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027 5.6 Threat of rivalry Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027 5.7 Market condition Exhibit 29: Chart on Market condition - Five forces 2022 and 2027 6 Market Segmentation by Route of Administration 6.1 Market segments Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%) Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%) 6.2 Comparison by Route of Administration Exhibit 32: Chart on Comparison by Route of Administration Exhibit 33: Data Table on Comparison by Route of Administration 6.3 Oral - Market size and forecast 2022-2027 Exhibit 34: Chart on Oral - Market size and forecast 2022-2027 ($ billion) Exhibit 35: Data Table on Oral - Market size and forecast 2022-2027 ($ billion) Exhibit 36: Chart on Oral - Year-over-year growth 2022-2027 (%) Exhibit 37: Data Table on Oral - Year-over-year growth 2022-2027 (%) 6.4 Topical - Market size and forecast 2022-2027 Exhibit 38: Chart on Topical - Market size and forecast 2022-2027 ($ billion) Exhibit 39: Data Table on Topical - Market size and forecast 2022-2027 ($ billion) Exhibit 40: Chart on Topical - Year-over-year growth 2022-2027 (%) Exhibit 41: Data Table on Topical - Year-over-year growth 2022-2027 (%) 6.5 Parenteral - Market size and forecast 2022-2027 Exhibit 42: Chart on Parenteral - Market size and forecast 2022-2027 ($ billion) Exhibit 43: Data Table on Parenteral - Market size and forecast 2022-2027 ($ billion) Exhibit 44: Chart on Parenteral - Year-over-year growth 2022-2027 (%) Exhibit 45: Data Table on Parenteral - Year-over-year growth 2022-2027 (%) 6.6 Others - Market size and forecast 2022-2027 Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ billion) Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ billion) Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%) Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%) 6.7 Market opportunity by Route of Administration Exhibit 50: Market opportunity by Route of Administration ($ billion) Exhibit 51: Data Table on Market opportunity by Route of Administration ($ billion) 7 Market Segmentation by Distribution Channel 7.1 Market segments Exhibit 52: Chart on Distribution Channel - Market share 2022-2027 (%) Exhibit 53: Data Table on Distribution Channel - Market share 2022-2027 (%) 7.2 Comparison by Distribution Channel Exhibit 54: Chart on Comparison by Distribution Channel Exhibit 55: Data Table on Comparison by Distribution Channel 7.3 Offline - Market size and forecast 2022-2027 Exhibit 56: Chart on Offline - Market size and forecast 2022-2027 ($ billion) Exhibit 57: Data Table on Offline - Market size and forecast 2022-2027 ($ billion) Exhibit 58: Chart on Offline - Year-over-year growth 2022-2027 (%) Exhibit 59: Data Table on Offline - Year-over-year growth 2022-2027 (%) 7.4 Online - Market size and forecast 2022-2027 Exhibit 60: Chart on Online - Market size and forecast 2022-2027 ($ billion) Exhibit 61: Data Table on Online - Market size and forecast 2022-2027 ($ billion) Exhibit 62: Chart on Online - Year-over-year growth 2022-2027 (%) Exhibit 63: Data Table on Online - Year-over-year growth 2022-2027 (%) 7.5 Market opportunity by Distribution Channel Exhibit 64: Market opportunity by Distribution Channel ($ billion) Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ billion) 8 Customer Landscape 8.1 Customer landscape overview Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria 9 Geographic Landscape 9.1 Geographic segmentation Exhibit 67: Chart on Market share by geography 2022-2027 (%) Exhibit 68: Data Table on Market share by geography 2022-2027 (%) 9.2 Geographic comparison Exhibit 69: Chart on Geographic comparison Exhibit 70: Data Table on Geographic comparison 9.3 North America - Market size and forecast 2022-2027 Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ billion) Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ billion) Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%) Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%) 9.4 Europe - Market size and forecast 2022-2027 Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ billion) Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ billion) Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%) Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%) 9.5 Asia - Market size and forecast 2022-2027 Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ billion) Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ billion) Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%) Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%) 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion) Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion) Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) 9.7 US - Market size and forecast 2022-2027 Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ billion) Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ billion) Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%) Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%) 9.8 Germany - Market size and forecast 2022-2027 Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ billion) Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ billion) Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%) Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%) 9.9 Japan - Market size and forecast 2022-2027 Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ billion) Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ billion) Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%) Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%) 9.10 UK - Market size and forecast 2022-2027 Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ billion) Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ billion) Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%) Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%) 9.11 China - Market size and forecast 2022-2027 Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ billion) Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ billion) Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%) Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%) 9.12 Market opportunity by geography Exhibit 107: Market opportunity by geography ($ billion) Exhibit 108: Data Tables on Market opportunity by geography ($ billion) 10 Drivers, Challenges, and Trends 10.1 Market drivers 10.2 Market challenges 10.3 Impact of drivers and challenges Exhibit 109: Impact of drivers and challenges in 2022 and 2027 10.4 Market trends 11 Vendor Landscape 11.1 Overview 11.2 Vendor landscape Exhibit 110: Overview on Criticality of inputs and Factors of differentiation 11.3 Landscape disruption Exhibit 111: Overview on factors of disruption 11.4 Industry risks Exhibit 112: Impact of key risks on business 12 Vendor Analysis 12.1 Vendors covered Exhibit 113: Vendors covered 12.2 Market positioning of vendors Exhibit 114: Matrix on vendor position and classification 12.3 Abbott Laboratories Exhibit 115: Abbott Laboratories - Overview Exhibit 116: Abbott Laboratories - Business segments Exhibit 117: Abbott Laboratories - Key news Exhibit 118: Abbott Laboratories - Key offerings Exhibit 119: Abbott Laboratories - Segment focus 12.4 Achelios Therapeutics Inc. Exhibit 120: Achelios Therapeutics Inc. - Overview Exhibit 121: Achelios Therapeutics Inc. - Product / Service Exhibit 122: Achelios Therapeutics Inc. - Key offerings 12.5 AstraZeneca Plc Exhibit 123: AstraZeneca Plc - Overview Exhibit 124: AstraZeneca Plc - Product / Service Exhibit 125: AstraZeneca Plc - Key news Exhibit 126: AstraZeneca Plc - Key offerings 12.6 Bayer AG Exhibit 127: Bayer AG - Overview Exhibit 128: Bayer AG - Business segments Exhibit 129: Bayer AG - Key news Exhibit 130: Bayer AG - Key offerings Exhibit 131: Bayer AG - Segment focus 12.7 BioGaia AB Exhibit 132: BioGaia AB - Overview Exhibit 133: BioGaia AB - Business segments Exhibit 134: BioGaia AB - Key news Exhibit 135: BioGaia AB - Key offerings Exhibit 136: BioGaia AB - Segment focus 12.8 Boehringer Ingelheim International GmbH Exhibit 137: Boehringer Ingelheim International GmbH - Overview Exhibit 138: Boehringer Ingelheim International GmbH - Business segments Exhibit 139: Boehringer Ingelheim International GmbH - Key news Exhibit 140: Boehringer Ingelheim International GmbH - Key offerings Exhibit 141: Boehringer Ingelheim International GmbH - Segment focus 12.9 Bukwang Pharmaceutical Co. Ltd. Exhibit 142: Bukwang Pharmaceutical Co. Ltd. - Overview Exhibit 143: Bukwang Pharmaceutical Co. Ltd. - Product / Service Exhibit 144: Bukwang Pharmaceutical Co. Ltd. - Key offerings 12.10 Chr Hansen Holding AS Exhibit 145: Chr Hansen Holding AS - Overview Exhibit 146: Chr Hansen Holding AS - Business segments Exhibit 147: Chr Hansen Holding AS - Key news Exhibit 148: Chr Hansen Holding AS - Key offerings Exhibit 149: Chr Hansen Holding AS - Segment focus 12.11 CVS Health Corp. Exhibit 150: CVS Health Corp. - Overview Exhibit 151: CVS Health Corp. - Business segments Exhibit 152: CVS Health Corp. - Key news Exhibit 153: CVS Health Corp. - Key offerings Exhibit 154: CVS Health Corp. - Segment focus 12.12 GlaxoSmithKline Plc Exhibit 155: GlaxoSmithKline Plc - Overview Exhibit 156: GlaxoSmithKline Plc - Business segments Exhibit 157: GlaxoSmithKline Plc - Key news Exhibit 158: GlaxoSmithKline Plc - Key offerings Exhibit 159: GlaxoSmithKline Plc - Segment focus 12.13 Johnson and Johnson Services Inc. Exhibit 160: Johnson and Johnson Services Inc. - Overview Exhibit 161: Johnson and Johnson Services Inc. - Business segments Exhibit 162: Johnson and Johnson Services Inc. - Key news Exhibit 163: Johnson and Johnson Services Inc. - Key offerings Exhibit 164: Johnson and Johnson Services Inc. - Segment focus 12.14 Novartis AG Exhibit 165: Novartis AG - Overview Exhibit 166: Novartis AG - Business segments Exhibit 167: Novartis AG - Key offerings Exhibit 168: Novartis AG - Segment focus 12.15 Pfizer Inc. Exhibit 169: Pfizer Inc. - Overview Exhibit 170: Pfizer Inc. - Product / Service Exhibit 171: Pfizer Inc. - Key news Exhibit 172: Pfizer Inc. - Key offerings 12.16 Reckitt Benckiser Group Plc Exhibit 173: Reckitt Benckiser Group Plc - Overview Exhibit 174: Reckitt Benckiser Group Plc - Business segments Exhibit 175: Reckitt Benckiser Group Plc - Key offerings Exhibit 176: Reckitt Benckiser Group Plc - Segment focus 12.17 Sanofi SA Exhibit 177: Sanofi SA - Overview Exhibit 178: Sanofi SA - Business segments Exhibit 179: Sanofi SA - Key news Exhibit 180: Sanofi SA - Key offerings Exhibit 181: Sanofi SA - Segment focus 13 Appendix 13.1 Scope of the report 13.2 Inclusions and exclusions checklist Exhibit 182: Inclusions checklist Exhibit 183: Exclusions checklist 13.3 Currency conversion rates for US$ Exhibit 184: Currency conversion rates for US$ 13.4 Research methodology Exhibit 185: Research methodology Exhibit 186: Validation techniques employed for market sizing Exhibit 187: Information sources 13.5 List of abbreviations Exhibit 188: List of abbreviations Exhibits: Exhibits1: Executive Summary - Chart on Market Overview Exhibits2: Executive Summary - Data Table on Market Overview Exhibits3: Executive Summary - Chart on Global Market Characteristics Exhibits4: Executive Summary - Chart on Market by Geography Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel Exhibits7: Executive Summary - Chart on Incremental Growth Exhibits8: Executive Summary - Data Table on Incremental Growth Exhibits9: Executive Summary - Chart on Vendor Market Positioning Exhibits10: Parent market Exhibits11: Market Characteristics Exhibits12: Offerings of vendors included in the market definition Exhibits13: Market segments Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion) Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion) Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%) Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) Exhibits18: Historic Market Size - Data Table on global over-the-counter drug market 2017 - 2021 ($ billion) Exhibits19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ billion) Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion) Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion) Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion) Exhibits23: Five forces analysis - Comparison between 2022 and 2027 Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027 Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027 Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027 Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027 Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027 Exhibits29: Chart on Market condition - Five forces 2022 and 2027 Exhibits30: Chart on Route of Administration - Market share 2022-2027 (%) Exhibits31: Data Table on Route of Administration - Market share 2022-2027 (%) Exhibits32: Chart on Comparison by Route of Administration Exhibits33: Data Table on Comparison by Route of Administration Exhibits34: Chart on Oral - Market size and forecast 2022-2027 ($ billion) Exhibits35: Data Table on Oral - Market size and forecast 2022-2027 ($ billion) Exhibits36: Chart on Oral - Year-over-year growth 2022-2027 (%) Exhibits37: Data Table on Oral - Year-over-year growth 2022-2027 (%) Exhibits38: Chart on Topical - Market size and forecast 2022-2027 ($ billion) Exhibits39: Data Table on Topical - Market size and forecast 2022-2027 ($ billion) Exhibits40: Chart on Topical - Year-over-year growth 2022-2027 (%) Exhibits41: Data Table on Topical - Year-over-year growth 2022-2027 (%) Exhibits42: Chart on Parenteral - Market size and forecast 2022-2027 ($ billion) Exhibits43: Data Table on Parenteral - Market size and forecast 2022-2027 ($ billion) Exhibits44: Chart on Parenteral - Year-over-year growth 2022-2027 (%) Exhibits45: Data Table on Parenteral - Year-over-year growth 2022-2027 (%) Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ billion) Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ billion) Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%) Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%) Exhibits50: Market opportunity by Route of Administration ($ billion) Exhibits51: Data Table on Market opportunity by Route of Administration ($ billion) Exhibits52: Chart on Distribution Channel - Market share 2022-2027 (%) Exhibits53: Data Table on Distribution Channel - Market share 2022-2027 (%) Exhibits54: Chart on Comparison by Distribution Channel Exhibits55: Data Table on Comparison by Distribution Channel Exhibits56: Chart on Offline - Market size and forecast 2022-2027 ($ billion) Exhibits57: Data Table on Offline - Market size and forecast 2022-2027 ($ billion) Exhibits58: Chart on Offline - Year-over-year growth 2022-2027 (%) Exhibits59: Data Table on Offline - Year-over-year growth 2022-2027 (%) Exhibits60: Chart on Online - Market size and forecast 2022-2027 ($ billion) Exhibits61: Data Table on Online - Market size and forecast 2022-2027 ($ billion) Exhibits62: Chart on Online - Year-over-year growth 2022-2027 (%) Exhibits63: Data Table on Online - Year-over-year growth 2022-2027 (%) Exhibits64: Market opportunity by Distribution Channel ($ billion) Exhibits65: Data Table on Market opportunity by Distribution Channel ($ billion) Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Exhibits67: Chart on Market share by geography 2022-2027 (%) Exhibits68: Data Table on Market share by geography 2022-2027 (%) Exhibits69: Chart on Geographic comparison Exhibits70: Data Table on Geographic comparison Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ billion) Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ billion) Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%) Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%) Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ billion) Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ billion) Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%) Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%) Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ billion) Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ billion) Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%) Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%) Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion) Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion) Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ billion) Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ billion) Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%) Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%) Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ billion) Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ billion) Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%) Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%) Exhibits95: Chart on Japan - Market size and forecast 2022-2027 ($ billion) Exhibits96: Data Table on Japan - Market size and forecast 2022-2027 ($ billion) Exhibits97: Chart on Japan - Year-over-year growth 2022-2027 (%) Exhibits98: Data Table on Japan - Year-over-year growth 2022-2027 (%) Exhibits99: Chart on UK - Market size and forecast 2022-2027 ($ billion) Exhibits100: Data Table on UK - Market size and forecast 2022-2027 ($ billion) Exhibits101: Chart on UK - Year-over-year growth 2022-2027 (%) Exhibits102: Data Table on UK - Year-over-year growth 2022-2027 (%) Exhibits103: Chart on China - Market size and forecast 2022-2027 ($ billion) Exhibits104: Data Table on China - Market size and forecast 2022-2027 ($ billion) Exhibits105: Chart on China - Year-over-year growth 2022-2027 (%) Exhibits106: Data Table on China - Year-over-year growth 2022-2027 (%) Exhibits107: Market opportunity by geography ($ billion) Exhibits108: Data Tables on Market opportunity by geography ($ billion) Exhibits109: Impact of drivers and challenges in 2022 and 2027 Exhibits110: Overview on Criticality of inputs and Factors of differentiation Exhibits111: Overview on factors of disruption Exhibits112: Impact of key risks on business Exhibits113: Vendors covered Exhibits114: Matrix on vendor position and classification Exhibits115: Abbott Laboratories - Overview Exhibits116: Abbott Laboratories - Business segments Exhibits117: Abbott Laboratories - Key news Exhibits118: Abbott Laboratories - Key offerings Exhibits119: Abbott Laboratories - Segment focus Exhibits120: Achelios Therapeutics Inc. - Overview Exhibits121: Achelios Therapeutics Inc. - Product / Service Exhibits122: Achelios Therapeutics Inc. - Key offerings Exhibits123: AstraZeneca Plc - Overview Exhibits124: AstraZeneca Plc - Product / Service Exhibits125: AstraZeneca Plc - Key news Exhibits126: AstraZeneca Plc - Key offerings Exhibits127: Bayer AG - Overview Exhibits128: Bayer AG - Business segments Exhibits129: Bayer AG - Key news Exhibits130: Bayer AG - Key offerings Exhibits131: Bayer AG - Segment focus Exhibits132: BioGaia AB - Overview Exhibits133: BioGaia AB - Business segments Exhibits134: BioGaia AB - Key news Exhibits135: BioGaia AB - Key offerings Exhibits136: BioGaia AB - Segment focus Exhibits137: Boehringer Ingelheim International GmbH - Overview Exhibits138: Boehringer Ingelheim International GmbH - Business segments Exhibits139: Boehringer Ingelheim International GmbH - Key news Exhibits140: Boehringer Ingelheim International GmbH - Key offerings Exhibits141: Boehringer Ingelheim International GmbH - Segment focus Exhibits142: Bukwang Pharmaceutical Co. Ltd. - Overview Exhibits143: Bukwang Pharmaceutical Co. Ltd. - Product / Service Exhibits144: Bukwang Pharmaceutical Co. Ltd. - Key offerings Exhibits145: Chr Hansen Holding AS - Overview Exhibits146: Chr Hansen Holding AS - Business segments Exhibits147: Chr Hansen Holding AS - Key news Exhibits148: Chr Hansen Holding AS - Key offerings Exhibits149: Chr Hansen Holding AS - Segment focus Exhibits150: CVS Health Corp. - Overview Exhibits151: CVS Health Corp. - Business segments Exhibits152: CVS Health Corp. - Key news Exhibits153: CVS Health Corp. - Key offerings Exhibits154: CVS Health Corp. - Segment focus Exhibits155: GlaxoSmithKline Plc - Overview Exhibits156: GlaxoSmithKline Plc - Business segments Exhibits157: GlaxoSmithKline Plc - Key news Exhibits158: GlaxoSmithKline Plc - Key offerings Exhibits159: GlaxoSmithKline Plc - Segment focus Exhibits160: Johnson and Johnson Services Inc. - Overview Exhibits161: Johnson and Johnson Services Inc. - Business segments Exhibits162: Johnson and Johnson Services Inc. - Key news Exhibits163: Johnson and Johnson Services Inc. - Key offerings Exhibits164: Johnson and Johnson Services Inc. - Segment focus Exhibits165: Novartis AG - Overview Exhibits166: Novartis AG - Business segments Exhibits167: Novartis AG - Key offerings Exhibits168: Novartis AG - Segment focus Exhibits169: Pfizer Inc. - Overview Exhibits170: Pfizer Inc. - Product / Service Exhibits171: Pfizer Inc. - Key news Exhibits172: Pfizer Inc. - Key offerings Exhibits173: Reckitt Benckiser Group Plc - Overview Exhibits174: Reckitt Benckiser Group Plc - Business segments Exhibits175: Reckitt Benckiser Group Plc - Key offerings Exhibits176: Reckitt Benckiser Group Plc - Segment focus Exhibits177: Sanofi SA - Overview Exhibits178: Sanofi SA - Business segments Exhibits179: Sanofi SA - Key news Exhibits180: Sanofi SA - Key offerings Exhibits181: Sanofi SA - Segment focus Exhibits182: Inclusions checklist Exhibits183: Exclusions checklist Exhibits184: Currency conversion rates for US$ Exhibits185: Research methodology Exhibits186: Validation techniques employed for market sizing Exhibits187: Information sources Exhibits188: List of abbreviations

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療/ヘルスケア）の最新刊レポート

TechNavio社のHealth Care分野での最新刊レポート

本レポートと同じKEY WORD（drug）の最新刊レポート


よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/18　10:27

154.74 円

162.88 円

199.42 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.